Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literature.
Mohamed ShokrAbdelrahman AhmedHossam AbubakarZiad SayedahmadAhmed RashedLuis AfonsoShaun CardozoPublished in: Clinical case reports (2018)
Direct oral anticoagulants can potentially provide a more convenient oral alternative for the management of left ventricular thrombi than Warfarin. These medications do not require frequent monitoring and have less drug-drug interactions. Randomized controlled trials are needed to further demonstrate their efficacy and safety in this setting.
Keyphrases
- direct oral anticoagulants
- left ventricular
- venous thromboembolism
- atrial fibrillation
- heart failure
- hypertrophic cardiomyopathy
- randomized controlled trial
- acute myocardial infarction
- cardiac resynchronization therapy
- left atrial
- mitral valve
- aortic stenosis
- systematic review
- clinical trial
- emergency department
- adverse drug
- oral anticoagulants
- smoking cessation
- electronic health record